Accomplished Pharma R&D leader, Sauri Gudlavalleti joins Sai Life Sciences as Chief Operating Officer
Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO-CDMO), today announced the appointment of Sauri Gudlavalleti as its Chief Operating Officer. Sauri will report to the CEO & Managing Director, Krishna Kanumuri and drive the company’s growth as a new generation, science-driven organization.
Accomplished Pharma R&D leader, Sauri Gudlavalleti joins Sai Life Sciences as Chief Operating Officer
Making the announcement, Krishna Kanumuri said, “I am really excited
to welcome Sauri on board Sai Life Sciences! He brings with him a strong
data-driven, systems approach combined with an innovation mindset and
customer focus. I am confident that this approach will help us build Sai
Life Sciences for greater scale, with high-quality science, speed and
operating efficiency as the key pivots of our growth.”
Sauri joins Sai Life Sciences from Dr. Reddy’s Laboratories where he
was heading Global R&D and Portfolio Management for small molecule
API & Formulations, encompassing portfolio & strategy,
development, technology transfer, CRO/ CDMO partnerships, IP, regulatory
affairs and clinical affairs. Over his 7-year tenure there, he
spearheaded a multifold increase in the R&D pipeline, significantly
globalized the R&D efforts with an impetus on fast-growing emerging
markets and brought about a pioneering transformation in R&D through
data and analytics. More recently, Sauri led the development, approval
and launch of the company’s covid portfolio, partnering with global
large pharma innovators, in record time.
Before Dr. Reddy’s, Sauri was at McKinsey & Co. for six years
where he successfully delivered on several client engagements with focus
on operational transformation spanning product development, service
delivery and manufacturing operations. Previously, he spent 9 years in
the US, working on advanced technologies at MIT, GE and Qualcomm. He
holds 9 US patents and has published in multiple peer-reviewed journals
and conferences. Sauri is a B.Tech from IIT Madras, an MS from MIT and
an MBA from IIM Ahmedabad.
Responding to his appointment, Sauri Gudlavalleti, COO said, “I am
delighted to join Sai Life Sciences at such an exciting time in its
journey. In all my interactions with the various leaders of the company,
I have sensed much excitement and a strong commitment to building a
high-quality scientific company that brings science to life for its
customers. This resonates with my own personal vision of transforming
Pharma R&D with innovative technologies, data and analytics.”
Over the past couple of years, the company has undergone an intense phase of transformation as part of its Sai Nxt initiative.
During this period, it has expanded into new geographies, executed
investments of over US$100M in its capacity and operations, grew its
workforce across locations, consolidated discovery operations from Pune
to Hyderabad, and more. As a result of these efforts, the progress in
its trajectory across both its Discovery and CMC businesses shows a
tremendous uptick in the recent months.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance